|
1
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2013. CA Cancer J Clin. 63:11–30. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bubendorf L, Schopfer A, Wagner U, et al:
Metastatic patterns of prostate cancer: An autopsy study of 1,589
patients. Hum Pathol. 31:578–583. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wang XY, Hao JW, Zhou RJ, et al:
Meta-analysis of gene expression data identifies causal genes for
prostate cancer. Asian Pac J Cancer Prev. 14:457–461. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Agre P, King LS, Yasui M, et al: Aquaporin
water channels-from atomic structure to clinical medicine. J
Physiol. 542:3–16. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hara-Chikuma M and Verkman AS: Prevention
of skin tumorigenesis and impairment of epidermal cell
proliferation by targeted aquaporin-3 gene disruption. Mol Cell
Biol. 28:326–332. 2008. View Article : Google Scholar :
|
|
6
|
Moon C, Soria JC, Jang SJ, et al:
Involvement of aquaporins in colorectal carcinogenesis. Oncogene.
22:6699–6703. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Shi YH, Chen R, Talafu T, Nijiati R and
Lalai S: Significance and expression of aquaporin 1, 3, 8 in
cervical carcinoma in Xinjiang Uygur women of China. Asian Pac J
Cancer Prev. 13:1971–1975. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
HU J and Verkman AS: Increased migration
and metastatic potential of tumor cells expressing aquaporin water
channels. Faseb J. 20:1892–1894. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ding T, Ma YJ, Li W, et al: Role of
aquaporin-4 in the regulation of migration and invasion of human
glioma cells. Int J Oncol. 38:1521–1531. 2011.PubMed/NCBI
|
|
10
|
Shi YH, Rehemu N, Ma H, Tuokan T, Chen R
and Suzuke L: Increased migration and local invasion potential of
SiHa cervical cancer cells expressing Aquaporin 8. Asian Pac J
Cancer Prev. 14:1825–1828. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Liu SL, Zhang SY, Jiang H, Yang YX and
Jiang Y: Co-expression of AQP3 and AQP5 in esophageal squamous cell
carcinoma correlates with aggressive tumor progression and poor
prognosis. Med Oncol. 30:2013. View Article : Google Scholar
|
|
12
|
Ismail M, Bokaee S, Davies J, Harrington
KJ and Pandha H: Inhibition of the aquaporin 3 water channel
increases the sensitivity of prostate cancer cells to cryotherapy.
Br J Cancer. 100:1889–1895. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Gueron G, De Siervi A and Vazquez E:
Advanced prostate cancer: reinforcing the strings between
inflammation and the metastatic behavior. Prostate Cancer Prostatic
Dis. 15:213–221. 2012. View Article : Google Scholar
|
|
14
|
Liu HQ, Song S, Wang JH and Zhang SL:
Expression of MMP-3 and TIMP-3 in gastric cancer tissue and its
clinical significance. Oncology Lett. 2:1319–1322. 2011.
|
|
15
|
Shen L, Zhu ZC, Huang Y, et al: Expression
profile of multiple aquaporins in human gastric carcinoma and its
clinical significance. Biomed Pharmacother. 64:313–318. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Liu W, Wang K, Gong K, Li X and Luo K:
Epidermal growth factor enhances MPC-83 pancreatic cancer cell
migration through the upregulation of aquaporin 3. Mol Med Rep.
6:607–610. 2012.PubMed/NCBI
|
|
17
|
Kusayama M, Wada K, Nagata M, et al:
Critical role of aquaporin 3 on growth of human esophageal and oral
squamous cell carcinoma. Cancer Sci. 102:1128–1136. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Li A, Lu D, Zhang Y, et al: Critical role
of aquaporin-3 in epidermal growth factor-induced migration of
colorectal carcinoma cells and its clinical significance. Oncol
Rep. 29:535–540. 2013.
|
|
19
|
Xu H, Xu Y, Zhang WJ, Shen LZ, Yang L and
Xu ZK: Aquaporin-3 positively regulates matrix metalloproteinases
via PI3K/AKT signal pathway in human gastric carcinoma SGC7901
cells. J Exp Clin Cancer Res. 30:2011. View Article : Google Scholar
|
|
20
|
Hara-Chikuma M and Verkman AS: Aquaporin-3
facilitates epidermal cell migration and proliferation during wound
healing. J Mol Med (Berl). 86:221–231. 2008. View Article : Google Scholar
|
|
21
|
Kohno M and Pouyssegur J: Targeting the
ERK signaling pathway in cancer therapy. Ann Med. 38:200–211. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Gialeli C, Theocharis AD and Karamanos NK:
Roles of matrix metalloproteinases in cancer progression and their
pharmacological targeting. Febs J. 278:16–27. 2011. View Article : Google Scholar
|
|
23
|
Jung K, Nowak L, Lein M, Priem F, Schnorr
D and Loening SA: Matrix metalloproteinases 1 and 3, tissue
inhibitor of metalloproteinase-1 and the complex of
metalloproteinase-1/tissue inhibitor in plasma of patients with
prostate cancer. Int J Cancer. 74:220–223. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhang M, Dai C, Zhu H, et al: Cyclophilin
A promotes human hepatocellular carcinoma cell metastasis via
regulation of MMP3 and MMP9. Mol Cell Biochem. 357:387–395. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Cho SJ, Chae MJ, Shin BK, Kim HK and Kim
A: Akt- and MAPK-mediated activation and secretion of MMP-9 into
stroma in breast cancer cells upon heregulin treatment. Mol Med
Rep. 1:83–88. 2008.PubMed/NCBI
|
|
26
|
Wang Q, Tang H, Yin S and Dong C:
Downregulation of microRNA-138 enhances the proliferation,
migration and invasion of cholangiocarcinoma cells through the
upregulation of RhoC/p-ERK/MMP-2/MMP-9. Oncol Rep. 29:2046–2052.
2013.PubMed/NCBI
|
